< Back to previous page
Researcher
Hatice Satilmis
- Keywords:Medicine
- Disciplines:Cancer therapy, Hematology, Applied immunology
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From3 Mar 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Oct 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Oct 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Nov 2019 → 30 Sep 2020 - Faculty of Medicine and Pharmacy (Faculty)
Member
From28 Sep 2017 → 26 Jun 2019
Publications
1 - 4 of 4
- Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis(2023)
Authors: Arne Van der Vreken, Inge Oudaert, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Ann Massie, Kim De Veirman, et al.
Pages: 112-123 - Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma(2023)
Authors: Rong Fan, Hatice Satilmis, Niels Vandewalle, Emma Verheye, Philip Vlummens, Anke Maes, Catharina Muylaert, Elke De Bruyne, Eline Menu, Holly Evans, et al.
- Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism(2023)
Authors: Hatice Satilmis, Emma Verheye, Philip Vlummens, Inge Oudaert, Niels Vandewalle, Rong Fan, Jennifer Knight, Nathan De Beule, Gamze Ates, Ann Massie, et al.
Pages: 69–80 - Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis(2022)
Authors: Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, et al.
Pages: 45